# üöÄ Pharmyrus API v3.0 - URLs PARA TESTAR

## üî¨ PIPELINE COMPLETO (NOVO!)

Base URL: `https://pharmyrus-total10-production.up.railway.app`

### ‚úÖ Busca Completa por Mol√©cula

**Endpoint:** `/api/v1/search/{molecule}?country={filter}&limit={num}`

**O que faz:**
1. üìä **PubChem** ‚Üí Busca sin√¥nimos, dev codes, CAS, propriedades qu√≠micas
2. üîç **Google Patents** ‚Üí Descobre WO numbers (m√∫ltiplas queries em paralelo)
3. üìÑ **WIPO + Google Details** ‚Üí Busca detalhes completos de cada WO (batch)
4. üáßüá∑ **INPI Brasil** ‚Üí Busca patentes BR diretas
5. üíä **FDA** ‚Üí Dados regulat√≥rios e aprova√ß√µes
6. üè• **ClinicalTrials.gov** ‚Üí Estudos cl√≠nicos

**Tempo de resposta:** ~30-60 segundos (processamento paralelo)

---

## üß™ MOL√âCULAS TESTADAS

### 1. Darolutamide (Oncologia - Pr√≥stata)
```
‚úÖ B√°sico:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/darolutamide

‚úÖ Filtro Brasil apenas:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/darolutamide?country=BR

‚úÖ Filtro m√∫ltiplos pa√≠ses:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/darolutamide?country=BR_US_JP

‚úÖ Com limit:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/darolutamide?country=BR&limit=5
```

### 2. Olaparib (Oncologia - PARP Inhibitor)
```
‚úÖ B√°sico:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/olaparib

‚úÖ Brasil + US:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/olaparib?country=BR_US

‚úÖ Top 3 WO patents:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/olaparib?limit=3
```

### 3. Venetoclax (Oncologia - Leucemia)
```
‚úÖ B√°sico:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/venetoclax

‚úÖ Brasil + Europa + US:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/venetoclax?country=BR_EP_US
```

### 4. Axitinib (Oncologia - Renal)
```
‚úÖ B√°sico:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/axitinib

‚úÖ BRICS:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/axitinib?country=BR_CN_IN
```

### 5. Niraparib (Oncologia - Ov√°rio)
```
‚úÖ B√°sico:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/niraparib
```

### 6. Tivozanib (Oncologia - Renal)
```
‚úÖ B√°sico:
https://pharmyrus-total10-production.up.railway.app/api/v1/search/tivozanib
```

---

## üìã ESTRUTURA DO JSON DE RESPOSTA

```json
{
  "executive_summary": {
    "molecule_name": "darolutamide",
    "generic_name": "DAROLUTAMIDE",
    "commercial_name": "Nubeqa",
    "cas_number": "1297550-10-5",
    "dev_codes": ["ODM-201", "BAY-1841788"],
    "total_patents": 150,
    "total_wo_patents": 25,
    "total_br_patents": 13,
    "jurisdictions": {
      "brazil": 13,
      "usa": 55,
      "europe": 10,
      "china": 12,
      "japan": 8,
      "worldwide": 25
    },
    "fda_status": "Approved",
    "clinical_trials_count": 245,
    "search_timestamp": "2025-12-10T..."
  },
  
  "pubchem_data": {
    "cid": 123456,
    "iupac_name": "...",
    "molecular_formula": "C19H19ClF2N4O2",
    "molecular_weight": 408.8,
    "smiles": "...",
    "inchi": "...",
    "inchi_key": "...",
    "synonyms": ["ODM-201", "BAY-1841788", ...],
    "dev_codes": ["ODM-201", "BAY-1841788"],
    "cas_number": "1297550-10-5",
    "xlogp": 3.4,
    "tpsa": 92.5,
    "hydrogen_bond_donors": 2,
    "hydrogen_bond_acceptors": 6,
    "rotatable_bonds": 4,
    "heavy_atom_count": 28
  },
  
  "search_strategy": {
    "molecule_searched": "darolutamide",
    "country_filter": "BR_US_JP",
    "layers_executed": [
      "PubChem",
      "Google Patents WO Search", 
      "Patent Details Batch (WIPO+Google)",
      "INPI Brasil",
      "FDA",
      "ClinicalTrials.gov"
    ],
    "parallel_processing": true,
    "sources": ["PubChem", "Google Patents", "WIPO", "INPI Brasil", "FDA", "ClinicalTrials.gov"]
  },
  
  "wo_patents": [
    {
      "wo_number": "WO2018162793",
      "title": "Combination therapy...",
      "abstract": "The present invention...",
      "assignees": ["Bayer Pharma AG", "Orion Corporation"],
      "inventors": ["John Doe", "Jane Smith"],
      "priority_date": "2017-03-10",
      "filing_date": "2018-03-09",
      "publication_date": "2018-09-13",
      "patent_family": ["BR", "US", "EP", "JP", "CN", "CA"],
      "worldwide_applications": {
        "BR": [
          {"document_id": "BR112019018744A2", "date": "2019-09-10"},
          {"document_id": "BR112019018744B1", "date": "2023-05-15"}
        ],
        "US": [
          {"document_id": "US20200038443A1", "date": "2020-02-06"}
        ]
      },
      "claims_count": 25,
      "citations_count": 45,
      "legal_status": "Active",
      "source": "wipo+google"
    }
  ],
  
  "br_patents_inpi": [
    {
      "publication_number": "BR-112019018744",
      "title": "Bayer Pharma AG",
      "abstract": "Combina√ß√£o farmac√™utica...",
      "filing_date": "2019-09-10",
      "assignee": "Bayer Pharma AG",
      "link": "https://busca.inpi.gov.br/...",
      "source": "inpi"
    }
  ],
  
  "all_patents": [
    {
      "publication_number": "WO2018162793",
      "title": "...",
      "abstract": "...",
      "assignees": ["Bayer Pharma AG"],
      "inventors": ["..."],
      "filing_date": "2018-03-09",
      "publication_date": "2018-09-13",
      "priority_date": "2017-03-10",
      "jurisdiction": "WO",
      "legal_status": "Active",
      "source": "wipo",
      "patent_family_size": 25
    },
    {
      "publication_number": "BR112019018744A2",
      "title": "...",
      "assignees": ["Bayer Pharma AG"],
      "filing_date": "2019-09-10",
      "jurisdiction": "BR",
      "source": "wipo_worldwide",
      "parent_wo": "WO2018162793"
    }
  ],
  
  "fda_data": {
    "molecule_name": "darolutamide",
    "fda_approval_status": "Approved",
    "fda_applications": [...],
    "marketing_status": "HUMAN PRESCRIPTION DRUG",
    "approval_date": "2019-07-30",
    "sponsor": "Bayer HealthCare",
    "indications": ["Treatment of non-metastatic castration-resistant prostate cancer..."],
    "data_source": "FDA APIs",
    "fetch_timestamp": "2025-12-10T..."
  },
  
  "clinical_trials_data": {
    "molecule_name": "darolutamide",
    "total_trials": 245,
    "trials_by_phase": {
      "Phase 1": 15,
      "Phase 2": 45,
      "Phase 3": 120,
      "Phase 4": 65
    },
    "trials_by_status": {
      "Recruiting": 25,
      "Active, not recruiting": 50,
      "Completed": 150,
      "Terminated": 10,
      "Unknown": 10
    },
    "primary_sponsors": ["Bayer", "Orion Corporation", ...],
    "countries": ["United States", "Brazil", "Japan", "Germany", ...]
  },
  
  "debug_info": {
    "total_duration_seconds": 45.67,
    "layers": [
      {
        "name": "PubChem",
        "status": "success",
        "duration": 2.34,
        "data_points": {
          "cid": 123456,
          "synonyms_found": 45,
          "dev_codes_found": 3,
          "cas_found": true
        }
      },
      {
        "name": "Google Patents WO Search",
        "status": "success",
        "duration": 12.56,
        "queries_executed": 13,
        "wo_numbers_found": 25
      },
      {
        "name": "Patent Details Batch (WIPO+Google)",
        "status": "success",
        "duration": 25.34,
        "total_wos": 25,
        "successful": 24,
        "failed": 1
      },
      {
        "name": "INPI Brasil",
        "status": "success",
        "duration": 8.45,
        "search_terms": 8,
        "br_patents_found": 13
      },
      {
        "name": "FDA",
        "status": "success",
        "duration": 1.23,
        "approval_found": true
      },
      {
        "name": "ClinicalTrials.gov",
        "status": "success",
        "duration": 3.45,
        "trials_found": 245
      }
    ],
    "timings": {
      "pubchem": 2.34,
      "google_patents_search": 12.56,
      "patent_details_batch": 25.34,
      "inpi_brasil": 8.45,
      "fda": 1.23,
      "clinical_trials": 3.45
    },
    "errors_count": 0,
    "warnings_count": 2,
    "errors": [],
    "warnings": [
      {
        "layer": "Google Search",
        "query": "darolutamide patent WO2024",
        "error": "timeout"
      }
    ]
  },
  
  "generated_at": "2025-12-10T15:30:45.123456"
}
```

---

## üéØ PAR√ÇMETROS SUPORTADOS

### Country Filter (opcional)
C√≥digos de pa√≠ses separados por underscore:
- `BR` - Brasil
- `US` - Estados Unidos
- `EP` - Europa (EPO)
- `JP` - Jap√£o
- `CN` - China
- `CA` - Canad√°
- `AU` - Austr√°lia
- `KR` - Coreia do Sul
- `IN` - √çndia

**Exemplos:**
- `?country=BR` - Apenas Brasil
- `?country=BR_US` - Brasil + EUA
- `?country=BR_US_JP_EP` - 4 pa√≠ses
- Sem par√¢metro = Todos os pa√≠ses

### Limit (opcional)
N√∫mero m√°ximo de WO patents a buscar detalhes:
- `?limit=5` - Busca apenas top 5 WO numbers
- `?limit=10` - Padr√£o
- `?limit=20` - M√°ximo recomendado

---

## üîß ENDPOINTS AUXILIARES

### 1. Home / Documenta√ß√£o
```
https://pharmyrus-total10-production.up.railway.app/
```

### 2. Health Check
```
https://pharmyrus-total10-production.up.railway.app/health
```

### 3. Swagger UI
```
https://pharmyrus-total10-production.up.railway.app/docs
```

### 4. Cache Stats
```
https://pharmyrus-total10-production.up.railway.app/api/cache/stats
```

### 5. WIPO Direto (sem pipeline)
```
# Teste simples
https://pharmyrus-total10-production.up.railway.app/test/WO2018162793

# Com filtro de pa√≠s
https://pharmyrus-total10-production.up.railway.app/api/v1/wipo/WO2018162793?country=BR
```

---

## ‚è±Ô∏è PERFORMANCE ESPERADA

| Camada | Tempo M√©dio | Descri√ß√£o |
|--------|-------------|-----------|
| PubChem | 1-3s | Dados qu√≠micos |
| Google Patents WO Search | 10-15s | Busca WO numbers (13 queries paralelas) |
| Patent Details Batch | 20-30s | Detalhes de cada WO (paralelo) |
| INPI Brasil | 5-10s | Patentes BR diretas |
| FDA | 1-2s | Dados regulat√≥rios |
| ClinicalTrials | 2-4s | Estudos cl√≠nicos |
| **TOTAL** | **40-65s** | **Pipeline completo** |

---

## üé® DIFEREN√áAS v2.0 ‚Üí v3.0

### v2.0 (Antigo)
```
GET /api/v1/search/darolutamide
‚Üì
{
  "error": "Endpoint em desenvolvimento",
  "suggestion": "Use /api/v1/wipo/WO2018162793"
}
```

### v3.0 (Novo) üöÄ
```
GET /api/v1/search/darolutamide?country=BR
‚Üì
{
  "executive_summary": {...},      ‚Üê Resumo executivo
  "pubchem_data": {...},            ‚Üê 50+ propriedades qu√≠micas
  "wo_patents": [25 patents],       ‚Üê 25 WO patents completos
  "br_patents_inpi": [13 patents],  ‚Üê 13 BR do INPI
  "all_patents": [150 patents],     ‚Üê Agrega√ß√£o total
  "fda_data": {...},                ‚Üê FDA completo
  "clinical_trials_data": {...},    ‚Üê 245 estudos
  "debug_info": {...}               ‚Üê Timings detalhados
}
```

---

## üìä M√âTRICAS DE QUALIDADE

A resposta inclui m√©tricas autom√°ticas:

```json
{
  "debug_info": {
    "layers": [
      {
        "name": "PubChem",
        "status": "success",
        "duration": 2.34,
        "data_points": {
          "synonyms_found": 45,
          "dev_codes_found": 3,
          "cas_found": true
        }
      }
    ],
    "errors_count": 0,
    "warnings_count": 2
  }
}
```

---

## üêõ DEBUG MODE

Toda resposta inclui `debug_info` com:
- ‚è±Ô∏è Timing de cada camada
- ‚úÖ Status de sucesso/falha
- ‚ö†Ô∏è Warnings (timeouts, queries sem resultado)
- ‚ùå Errors (falhas cr√≠ticas)
- üìä Data points coletados por camada

---

## üîÑ RETRY & FALLBACK

O pipeline √© resiliente:
- Timeouts individuais por layer
- Continue-on-error para layers opcionais
- Cache autom√°tico de WO patents
- Retry autom√°tico para falhas tempor√°rias

---

## üí° DICAS DE USO

1. **Primeira busca**: Pode demorar 60s (sem cache)
2. **Buscas subsequentes**: WO patents ficam em cache (instant√¢neo)
3. **Filtro de pa√≠s**: Aplique DEPOIS da busca (n√£o reduz tempo)
4. **Limit**: Use para acelerar testes (limit=3)
5. **Molecules testadas**: Use as 6 oncol√≥gicas para garantir resultados

---

## üö® TROUBLESHOOTING

### Timeout (>60s)
```
Causa: Muitos WO numbers encontrados
Solu√ß√£o: Use ?limit=5
```

### Poucos resultados
```
Causa: Mol√©cula muito nova ou gen√©rica
Solu√ß√£o: Verifique nome correto no PubChem
```

### Erro 500
```
Causa: Servi√ßo externo indispon√≠vel
Solu√ß√£o: Retry ap√≥s 1min ou consulte debug_info
```

---

## üìû SUPORTE

Base URL Railway: `https://pharmyrus-total10-production.up.railway.app`

Documenta√ß√£o interativa: `/docs`
